Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Tactiva Therapeutics

Tactiva Therapeutics

Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.

OverviewStructured DataIssuesContributorsActivity

Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies that is headquartered in Buffalo, New York and was founded in 2016 by Kunle Odunsi, Richard Koya, and Mathew Colpoys.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Founder Kunle Odunsi Elected to National Academy of Medicine

Tactavia Therapeutics

https://www.prnewswire.com/news-releases/tactiva-therapeutics-co-founder-kunle-odunsi-elected-to-national-academy-of-medicine-300734000.html

Web

Tactiva Therapeutics Secures $35 Million Series A Financing to Pursue Clinical Development of DEACT Platform

Tactavia Therapeutics

https://www.prnewswire.com/news-releases/tactiva-therapeutics-secures-35-million-series-a-financing-to-pursue-clinical-development-of-deact-platform-300758786.html

Web

Tactiva Therapeutics: ESD announces launch of innovative immunotherapy biotech company based in Buffalo

Niagara Frontier Publications

https://www.wnypapers.com/news/article/current/2017/02/03/127463/tactiva-therapeutics-esd-announces-launch-of-innovative-immunotherapy-biotech-company-based-in-buffalo

Web

References

Find more companies like Tactiva Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo